Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ

$11.08

$+0.10

(+0.87%)

Regular Market

Xeris Biopharma Holdings, Inc. (XERS) Live Price Chart

Last updated: ⁦2026-10-20 14:05:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Xeris Biopharma Holdings, Inc. (XERS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $11.08, with a market capitalization of $1.88B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.25 to $11.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.88B
Open	$11.01
Day's High	$27.98
Day's Low	$0.97
Previous Close	$10.95
Volume	205.13K
Average Volume	2.30M
P/E Ratio	--
52-Week High	$11.42
52-Week Low	$5.25
Dividend Yield	--
Earnings Date	--

Xeris Biopharma Holdings, Inc. (XERS) Stock Price Today

Xeris Biopharma Holdings, Inc. (XERS) is currently trading at $11.08 as of 2026-10-20 14:03:00, up 1.17% ($0.13) from the previous close of $10.95

During today's regular trading session, XERS has traded between $0.97 and $27.98, with a trading volume of 205.13K shares. The current price is near the middle of today's range.

Xeris Biopharma Holdings, Inc. (XERS) 7-Day Stock Price Change

Over the past seven days, Xeris Biopharma Holdings, Inc. (XERS) moved from $10.48 to $11.08, representing a gain of 5.71% ($0.60).

The stock traded between $9.73 and $11.42 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.50 million shares, down versus the previous seven-day period, indicating lower trading activity.

XERS 52-Week Price Position

Position in Range: 94.5%

52W Low$5.25

52W High$11.42

XERS is currently trading at $11.08, placing it 94.5% of the way from its 52-week low of $5.25 to its 52-week high of $11.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Xeris Biopharma Holdings, Inc. (XERS)?

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Xeris Biopharma Holdings, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	435
Exchange	NASDAQ
Company Website	https://www.xerispharma.com

How to Buy Xeris Biopharma Holdings, Inc. (XERS) Stock on MEXC

Eligible investors can buy real shares of Xeris Biopharma Holdings, Inc. (XERS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for XERS and Place Your Order

Open the RealStocks trading page and search for XERS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Xeris Biopharma Holdings, Inc. (XERS) stock price today?

Xeris Biopharma Holdings, Inc. (XERS) is currently trading at $ 11.08, up 1.17% ($0.13) from the previous close of $ 10.95. Intraday prices update in real time during regular trading hours.

2.Is XERS stock going up or down today?

As of 2026-10-20 14:03:00, XERS is trading at $ 11.08, up 1.17% ($0.13) from its previous close of $ 10.95. The stock has traded between $ 0.97 and $ 27.98 during today’s regular session. Past price movements do not guarantee future results.

3.What is XERS pre-market price?

As of 2026-10-20 14:03:00, XERS is trading at $ 11.01 in pre-market trading, up 0.50% ($0.06) from the previous close of $ 10.95. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is XERS after-hours price?

As of 2026-10-20 14:03:00, XERS is trading at $ 10.99 in after-hours trading, up 0.37% ($0.04) from the regular-session close of $ 10.95. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is XERS stock trading now?

XERS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does XERS sit relative to its 52-week high and low?

Over the past 52 weeks, XERS has traded between a low of $ 5.25 and a high of $ 11.42. At $ 11.08, the stock is positioned 94.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Xeris Biopharma Holdings, Inc. in?

Xeris Biopharma Holdings, Inc. (XERS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Xeris Biopharma Holdings, Inc.'s market capitalization and where is it listed?

Xeris Biopharma Holdings, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.88B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is XERS valued in terms of P/E ratio and EPS?

XERS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.09. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Xeris Biopharma Holdings, Inc. pay a dividend?

Xeris Biopharma Holdings, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.